Nexalin Technology Rule of 40

Mitä Nexalin Technology tekee? Nexalin Technology Inc, headquartered in Laguna Niguel, California, designs and develops neurostimulation products within the US health care sector. Listed on September 16, 2022, the company employs six full-time staff members. Its flagship device, Generation 1, utilizes bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The non-invasive system applies a high-frequency, charge-balanced electrical current waveform via head electrodes, offering relief without adverse side effects. Additionally, Nexalin is designing clinical trials for Generation 2, targeting substance use disorders, particularly opiate abuse, as well as chronic pain, Alzheimer’s disease, and dementia. These devices operate using varying voltages and frequencies to address mental health issues effectively. Nexalin Technology on yksi Eurpooliin suosituimmista yhtiöistä.